In addition, cytokines such as TNFα and IL-6, which might participate in the pathogenesis of NASH, elicit changes in sphingolipid metabolism and stimulate the production of bioactive lipids, such as ceramide, which behave as second messengers [36]–[38]. The gene discussed is IL6; the disease is metabolic dysfunction-associated steatohepatitis.